- Case report
- Open Access
Serous labyrinthitis as a manifestation of cat scratch disease: a case report
© Kantas et al.; licensee Cases Network Ltd. 2009
- Received: 25 June 2008
- Accepted: 10 June 2009
- Published: 15 September 2009
Cat scratch disease is an infectious disease transmitted by young cats, in which the principal causative factor is Bartonella henselae. The typical course of cat scratch disease is usually benign and self-limited and requires only supportive therapy. However, cases lasting up to 2 years have been reported, and more serious complications may occur. Many manifestations of the disease have been reported by different medical disciplines.
A case of cat scratch disease in a 71-year-old Greek woman with an unusual clinical course is presented here. Serous otitis media was combined with rotational vertigo due to labyrinthitis. The invaded ear was ipsilateral to the inoculation site.
Cervicofacial lymphadenopathy has been demonstrated as the most common otolaryngologic manifestation of cat scratch disease. Manifestation in the middle and inner ear has, to the best of our knowledge, not been reported before. Our report presents a patient with cat scratch disease with clinical signs and symptoms in the middle and inner ear.
- Spontaneous Nystagmus
- Bartonella Henselae
Selby and Walker advocated an avasculitic origin of cat scratch disease (CSD) after demonstrating cerebral arteritis in a 7-year-old girl suffering from CSD . In 1992, Regnery et al. reported Bartonella henselae to be the major causative agent of CSD . Therefore, CSD is considered as a zoonosis with many clinical manifestations as well as a cosmopolitan emerging human pathogen . Typical CSD can occur in all ages. Usually, 3 to 10 days after contact with an infected cat, most often a newly acquired kitten, a non-tender 1 mm to 10 mm red to brown papule develops, followed by prolonged regional lymphadenopathy for another 14 days.
Most authors have described typical CSD as a self-limited disease with a subsidence of symptoms within 2 to 4 months. However, cases lasting up to 2 years have been reported, and more serious complications may occur. Different organs can be affected, including the eyes, liver, spleen, central nervous system, skin and bones, among others [3, 4]. Many otolaryngologic manifestations of the disease have been observed. However, manifestations in the middle or inner ear have, to the best of our knowledge, not been reported so far. Our report presents a patient with CSD with clinical signs and symptoms in the middle and inner ear.
A 71-year-old Greek woman complaining of rotational vertigo was admitted to the ENT (ear, nose and throat) department at the "G. Genimmatas" General Hospital of Thessaloniki, for investigation and treatment. The patient had an unexplained fever, with an axillary body temperature of over 39°C, taken in several measurements during the 15 days before admission.
During ENT clinical examination and Romberg's test, the patient tended to fall towards the right. Observation using Frenzel glasses showed spontaneous nystagmus with the fast component toward the left.
Rinne's test was negative on the left and positive on the right ear, respectively. The patient localized the tone on the left side during Weber's test. Tympanometry appeared as a flat curve on the left side (a type B tympanogram) due to serous exudate in the middle ear. The right-ear tympanogram showed a normal type A curve. A pure-tone audiogram showed a conductive hearing loss on the left side with a gap of 10 dB to 15 dB. On electronystagmography testing, the main abnormal finding was the presence of an intense spontaneous nystagmus of a peripheral type, both with and without an optic fixation. The direction of the fast phase of the nystagmus toward the site of the lesion along with the presence of a directional preponderance (83%) towards the side of the lesion showed an impaired horizontal semicircular canal of the left labyrinth.
Differential diagnosis for specific lymphadenopathy includes tuberculosis, sarcoidosis, syphilis, diphtheria, tularemia, toxoplasmosis and CSD. The specific history and the skin lesion pointed towards CSD. The chest radiogram was normal. Erythrocyte sedimentation rate was 78 mm per hour, and C-reactive protein was 56 mg/dL. Immunoglobin (Ig) M and IgG serologic control was negative for toxoplasmosis, cytomegalovirus, Epstein-Barr virus and HIV.
Serologic control for Bartonella henselae was sent to National Institute of Pasteur in Athens. Azithromycin was administered for 6 days in combination with methylprednisolone and dimenhydrinate during the wait for the test results, which confirmed the diagnosis of CSD. Paracentesis of the tympanic membrane was performed, and 2 cc of fluid materials from the mesotympanum were taken and sent for culture tests. After wide tympanostomy, mucosal pieces were taken from the promontory area using micro ear forceps with oval cupped jaws and sent for polymerase chain reaction (PCR) control. Culture results were negative for Bartonella henselae. Total DNA was isolated from promontory mucosal cells, according to the standard procedures (QIAGEN-Tissue DNA isolation kit, QIAGEN GmbH, Germany) and was used as a template in a real-time PCR (ROCHE LightCycler 1.1), with primers and probes (FRET technology) specially designed to multiply and detect the OspA region of Bartonella species (B. bacilliformis, B. elizabethae, B. vinsonii, B. quintana and B. henselae). The results obtained by the PCR analysis revealed the presence of Bartonella henselae DNA in the clinical specimen. The first serologic results for Bartonella henselae strengthened our suspicion for CSD (IgM: 20, IgG: 270). IgG blood antibodies increased impressively 3 weeks later (IgG: 1100). This four-fold rise of IgG blood antibodies finally confirmed the diagnosis of CSD. The patient was discharged from the hospital symptom-free one week after admission.
Epidemiologic studies revealed that owners of kittens younger than 12 months were 15 times more likely to develop CSD than owners of adult cats . Typical CSD can occur in immunocompromised or immunocompetent patients of all ages alike. The history is always associated with cat scratches, bites or exposure to cat saliva. The disease initially develops as a small skin lesion at the site of the scratch or bite, followed by a round red to brown, non-tender papule after 3 to 10 days .
Bartonella henselae is a proteobacteria that can cause bacteremia, endocarditis, bacillary angiomatosis, peliosis hepatis and CSD. The diagnosis of CSD is usually confirmed by the presence of IgM antibodies against B. henselae after serologic control and in combination with IgG antibodies at the first examination, which then shows a rising titer in a second serologic follow-up after 10 to 14 days . When it is not possible to isolate the causative agent within the labyrinthine fluids, identification of the agent within the tissue of the middle ear is almost as reliable . The histologic findings of invaded lymph nodes are inflammatory granulomas with micro-abscesses surrounded by histocytes, lymphocytes, occasional giant cells and fibrosis. In other words, they are very similar to the findings in other granulomatous diseases such as tularemia, lymphogranuloma venereum and brucellosis and have to be distinguished from these by molecular methods .
CSD may present in a typical or atypical fashion in both immunocompetent and immunocompromised patients. The spectrum of CSD includes lymphadenopathy, usually regional and unilateral, which occurs 1-3 weeks after the infecting cat scratch, with gradual nodal enlargement. Sometimes, patients appear to be quite well generally, with only mild, non-specific symptoms such as headache, anorexia, myalgia or abdominal pain .
The most typical manifestation of CSD is Parinaud's oculoglandular syndrome, consisting of unilateral preauricular lymphadenopathy and conjunctivitis . Unexplained fever, Keber's stellate neuroretinitis , endocarditis , encephalopathy , acute hemiplegia , facial palsy and partial ptosis  have all been reported as manifestations of CSD. Ridder et al.  described the most usual ENT manifestations of CSD in a number of the 99 patients they examined, after serologic confirmation in a retrospective analysis. These authors reported lymphadenopathy in 100% of cases as the first manifestation (acute, abscessed and chronic), followed by a swelling of the parotid lymph nodes (34.3%), pharyngitis (15.2%), fever (9.1%), Parinaud's syndrome (8.1%) and swelling of parotid gland (6.1%). As rare manifestations, they reported tonsillitis, laryngitis, and perichondritis of the auricle . The same first author reported a case of CSD mimicking a hypopharyngeal tumor .
Azithromycin has been advocated as modestly hastening the resolution of lymphadenopathy . Macrolides, rifampin, doxycycline, gentamicin, trimethoprim-sulfamethoxazole and ciproxin alone or in combination have also been suggested as agents for treatment.
The pathogenesis of CSD complications in the central nervous system still remains obscure. To the best of our knowledge, manifestation in the inner and middle ear have not been reported so far. The pathogenesis of serous labyrinthitis in our patient may be due to toxins present in the labyrinth, rather than due to the presence of bacteria in the inner ear.
The manifestation of CSD in the middle and inner ear is rare.
Written informed consent was obtained from the patient of this case report for publication and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Selby G, Walker GL: Cerebral arteritis in cat-scratch disease. Neurology. 1979, 29: 1413-1418.View ArticlePubMedGoogle Scholar
- Regnery RL, Olson JG, Perkins BA, Bibb W: Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease. Lancet. 1992, 339: 1443-1445. 10.1016/0140-6736(92)92032-B.View ArticlePubMedGoogle Scholar
- Anderson BE, Neuman MA: Bartonella spp as emerging human pathogens. Clin Microbiol Rev. 1997, 10: 203-219.PubMedPubMed CentralGoogle Scholar
- Bass JW, Vincet JM, Person DA: The expanding spectrum of Bartonella infections: II. Pediatr Infect Dis J. 1997, 16: 163-179. 10.1097/00006454-199702000-00002.View ArticlePubMedGoogle Scholar
- Zangwill KM, Hamilton DH, Perkins BA, Regnery RL, Plikaytis BD, Hadler JL, Cartter ML, Wenger JD: Cat scratch disease in Connecticut. Epidemiology risk factors and evaluation of a new diagnostic test. N Engl J Med. 1993, 329: 8-13. 10.1056/NEJM199307013290102.View ArticlePubMedGoogle Scholar
- Rocha JL, Pellegrino LN, Riella LV, Martins LT: Acute hemiplegia associated with cat-scratch disease. Brazil J Infect Dis. 2004, 8: 263-266. 10.1590/S1413-86702004000300012.View ArticleGoogle Scholar
- Ridder GJ, Boedeker CC, Technau-Ihling K, Sander A: Cat-scratch disease: otolaryngologic manifestations and management. Otolaryngol Head Neck Surg. 2005, 132: 353-358. 10.1016/j.otohns.2004.09.019.View ArticlePubMedGoogle Scholar
- Davis LE, Johnsson LG: Viral infections of the inner ear: clinical, virologic, and pathologic studies in humans and animals. Am J Otolaryngol. 1983, 4: 347-362. 10.1016/S0196-0709(83)80022-2.View ArticlePubMedGoogle Scholar
- Batts S, Demers DM: Spectrum and treatment of cat scratch disease. Pediatr Infect Dis J. 2004, 23: 1161-1162.PubMedGoogle Scholar
- Baorto E, Payne RM, Slater LN, Lopez F, Relman DA, Min KW, St Geme 3rd: Culture-negative endocarditis caused by Bartonella Henselae. J Pediatr. 1998, 132: 1051-1054. 10.1016/S0022-3476(98)70410-X.View ArticlePubMedGoogle Scholar
- Noah DL, Bresee JS, Gorensek MJ, Rooney JA, Cresanta JL, Regnery RL, Wong J, del Toro J, Olson JG, Childs JE: Cluster of five children with acute encephalopathy associated with cat-scratch disease in south Florida. Pediatr Infect Dis J. 1995, 14: 866-869. 10.1097/00006454-199510000-00009.View ArticlePubMedGoogle Scholar
- Ganesan K, Mizen K: Cat-scratch disease an unusual cause of facial palsy and partial ptosis: case report. J Oral Maxillofac Surg. 2005, 63: 869-872. 10.1016/j.joms.2004.05.222.View ArticlePubMedGoogle Scholar
- Ridder GJ, Richter B, Laszing R: A farmer with a lump in his throat. Lancet. 1998, 351: 954View ArticlePubMedGoogle Scholar
- Bass JW, Freitas BC, Freitas AD, Sisler CL, Chan DS, Vincent JM, Person DA, Claybaugh JR, Wittler RR, Weisse ME, Regnery RL, Slater LN: Prospective randomized prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J. 1998, 17: 447-452. 10.1097/00006454-199806000-00002.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.